Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Delmas

Bone

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Bone|July 28, 1999
Clinical use of selective estrogen receptor modulatorsP D Delmas
Bone|January 1, 1992
Clinical use of biochemical markers of bone remodeling in osteoporosisP D Delmas
Bone|June 27, 2001
Bone marker nomenclatureP D Delmas,
Bone|June 24, 2000
How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?P D Delmas
Bone|January 17, 2002
Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosisP D Delmas
Bone|January 1, 1991
The use of clodronate in multiple myelomaP D Delmas
Bone|February 14, 2003
An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosisP Garnero, P D Delmas
Bone|December 1, 1996
Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cellsP Szulc, P D Delmas
Bone|August 22, 2006
Bone width is correlated positively with the upper to the lower segment ratio in elderly men--the MINOS studyP Szulc, P D Delmas
Bone|May 10, 2001
The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of boneP Garnero, S Christgau, P D Delmas
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Bone|July 28, 1999
Clinical use of selective estrogen receptor modulatorsP D Delmas
Bone|January 1, 1992
Clinical use of biochemical markers of bone remodeling in osteoporosisP D Delmas
Bone|June 27, 2001
Bone marker nomenclatureP D Delmas,
Bone|June 24, 2000
How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?P D Delmas
Bone|January 17, 2002
Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosisP D Delmas
Bone|January 1, 1991
The use of clodronate in multiple myelomaP D Delmas
Bone|February 14, 2003
An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosisP Garnero, P D Delmas
Bone|December 1, 1996
Influence of vitamin D and retinoids on the gammacarboxylation of osteocalcin in human osteosarcoma MG63 cellsP Szulc, P D Delmas
Bone|August 22, 2006
Bone width is correlated positively with the upper to the lower segment ratio in elderly men--the MINOS studyP Szulc, P D Delmas
Bone|May 10, 2001
The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of boneP Garnero, S Christgau, P D Delmas
Pageof 6